Ono Pharmaceutical Co., Ltd. (Osaka, Japan, President and Representative Director: Gyo Sagara;“ONO”) announced today that it has launched Coralan? (generic name: ivabradine hydrochloride)Tablet 2.5mg, 5mg and 7.5mg (“Cor……
November 22, 2029, Merck, today announced that the European Commission has granted a conditional marketing authorization to ERVEBO for active immunization of individuals 28 years of age or older to protect against Ebola ……
Oct. 22, 2029 -- Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has expanded the label for Fiasp? (insulin aspart injection) 200 u/mL to include use in insulin infusion pumps for the improv……
23 September 2029 07:00 BST AstraZeneca today announced that Qtrilmet (metformin hydrochloride, saxagliptin and dapagliflozin) modified-release tablets have been recommended for marketing authorisation in ……
September 20, 2029 ― Almirall LLC announced today the FDA approval of the expanded indication for Aczone? 7.5% Gel to include patients aged 9-22. Aczone? 7.5% Gel is a prescription medicine used on the skin (topical) to ……
Aug. 30, 2029 -- CARsgen Therapeutics Inc., a clinical-stage biopharmaceutical company today announced the United States Food and Drug Administration (FDA) has granted orphan drug designation to its investiga……
Copyright Nanjing Dorra Pharmaceutical Technology Co.,Ltd. @ 2018 China All Rights Reserved 蘇ICP備12056923號(hào)-1
Tel: 025-82232955 025-82232966
Fax:025-82232933 025-82232944
E-mail: info@dorrapharma.com
